-+ 0.00%
-+ 0.00%
-+ 0.00%

Erasca appoints Charles Fuchs as president of R&D

PUBT·08/10/2026 12:07:35
Listen to the news
Erasca appoints Charles Fuchs as president of R&D
  • Erasca named Charles S. Fuchs president of research and development, effective immediately.
  • Fuchs most recently served as chief medical officer at Tubulis, where he led clinical strategy and pipeline development.
  • He previously held senior oncology drug development roles at Genentech and Roche, following earlier leadership posts at Yale Cancer Center and Dana-Farber.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Erasca Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608100800PRIMZONEFULLFEED9806331) on August 10, 2026, and is solely responsible for the information contained therein.